1. Home
  2. SLNG vs IMUX Comparison

SLNG vs IMUX Comparison

Compare SLNG & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stabilis Solutions Inc.

SLNG

Stabilis Solutions Inc.

HOLD

Current Price

$4.51

Market Cap

92.0M

Sector

Utilities

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$0.66

Market Cap

85.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLNG
IMUX
Founded
2013
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
92.0M
85.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SLNG
IMUX
Price
$4.51
$0.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$10.00
$6.00
AVG Volume (30 Days)
6.2K
1.6M
Earning Date
02-24-2026
02-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$72,270,000.00
N/A
Revenue This Year
$7.02
N/A
Revenue Next Year
$7.68
N/A
P/E Ratio
$80.86
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.29
$0.51
52 Week High
$8.28
$1.39

Technical Indicators

Market Signals
Indicator
SLNG
IMUX
Relative Strength Index (RSI) 47.85 55.18
Support Level $4.33 $0.61
Resistance Level $4.65 $0.71
Average True Range (ATR) 0.29 0.05
MACD -0.01 0.02
Stochastic Oscillator 49.45 78.50

Price Performance

Historical Comparison
SLNG
IMUX

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: